About
Collegium Pharmaceutical Inc (NASDAQ:COLL) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
Mar 19 2026
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
Mar 5 2026
Collegium to Present New Real-World Data at PainConnect 2026
Mar 3 2026
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
Feb 26 2026
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
Financials
Revenue
$780.57 M
Market Cap
$1.03 B
P/E Ratio
18.68
EPS
1.73
Translate